Next-generation therapies like CAR-T cell therapy and AAV delivery face challenges in maximizing efficacy and minimizing off-target effects, limiting their therapeutic potential. Current methods lack precise control over the distribution and targeting of these therapeutics within the body.

MiraCure is developing a micro-robotic system that uses magnetic guidance to enhance the precision and effectiveness of cell and gene therapies. Their platform allows for fine-grained, ex-vivo control of magnetized therapeutics, enabling healthcare providers to optimize treatment delivery. By applying magnetic fields and micro-robotics, MiraCure aims to improve targeting, reduce off-target effects, and ultimately maximize the therapeutic impact of advanced therapies like CAR-T and AAV. The system provides a novel approach to precisely manipulate and guide therapeutic agents to specific locations within the body.

Next-generation electromagnetic system for precise ex-vivo control.

Magnetic guidance of therapeutics to enhance targeting.

Micro-robotics platform for manipulating cells and gene therapies.

Optimization of CAR-T cell therapy delivery.

Enhanced AAV delivery for gene therapy applications.

The primary target audience includes healthcare providers and researchers working with cell and gene therapies, particularly those focused on CAR-T cell therapy and AAV delivery.